Journal ArticleOPEN ACCESS

Myasthenia Gravis Presenting as Graft versus Host Disease after Allogeneic Blood Stem Cell Transplant

  • Ahmed Z
  • Schoen M
  • Rajeh N
Case Reports in Hematology (2018) 2018 1-3
DOI: 10.1155/2018/7296930
N/ACitations
Citations of this article
7Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Myasthenia gravis is a very rare manifestation of graft versus host disease after stem cell transplants. Herein, we describe a case of new-onset myasthenia gravis after a stem cell transplant 34 months ago in a patient with myelodysplastic syndrome.

Cite

CITATION STYLE

APA

Ahmed, Z., Schoen, M., & Rajeh, N. (2018). Myasthenia Gravis Presenting as Graft versus Host Disease after Allogeneic Blood Stem Cell Transplant. Case Reports in Hematology, 2018, 1–3. https://doi.org/10.1155/2018/7296930

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free